CIK 0001514183 · Non-accelerated filer<br>Smaller reporting company
Silo Pharma, Inc.
Sign in to watch- Ticker
- SILO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462137136
- Phone
- (718) 400-9031
- Business address
- 677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
- Former names
- Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
- 4 Open-market buy CEO and President bought 1,100 shares at an average $1.52 ($1,668)
- 8-K Event Shareholder vote results
- 4 Open-market buy CEO and President bought 1,000 shares at an average $1.38 ($1,376)
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Shareholder vote results
- 4 Open-market buy CEO and President bought 2,000 shares at an average $1.55 ($3,100)
- 4 Open-market buy CEO and President bought 650 shares at an average $1.72 ($1,117)
- 4 Open-market buy CEO and President bought 4,350 shares at an average $1.60 ($6,948)
- 4 Open-market buy CEO and President bought 2,900 shares at an average $1.46 ($4,235)
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $2.13 ($2,126)
- 4 Open-market buy CEO and President bought 3,000 shares at an average $2.07 ($6,204)
- 10-Q Report Quarterly Report
Page 8 of 19 · 380 filings